Ferrante Karen Jean
SEC insider (Form 3/4/5 filer). CIK 0001598502. Director at Cogent Biosciences, Inc. (COGT) and 1 other issuer. 17 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WALTHAM, MA.
Companies Ferrante Karen Jean has filed insider reports for
- Cogent Biosciences, Inc. (COGT): Director
- MACROGENICS INC (MGNX): Director
Ferrante Karen Jean
CIK: 0001598502
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Oct 1, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
759 shares- - Jul 1, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
627 shares- - Jun 9, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
17.9K shares- - May 19, 2026MGNX
MACROGENICS INC
AwardDirectStock Option (right to buy)
22K shares- - May 19, 2026MGNX
MACROGENICS INC
AwardDirectRestricted Stock Unit
3.8K shares- - May 18, 2026MGNX
MACROGENICS INC
ExerciseDirect3.8K shares- - Apr 1, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
686 shares- - Jan 1, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
643 shares- - Oct 1, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
1.6K shares- - Jul 1, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
3.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 759 | - | - | Direct |
| Jul 1, 2026 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 627 | - | - | Direct |
| Jun 9, 2026 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 17,901 | - | - | Direct |
| May 19, 2026 |  MGNX MACROGENICS INC | Award Stock Option (right to buy) | 22,000 | - | - | Direct |
| May 19, 2026 | MGNX MACROGENICS INC | Award Restricted Stock Unit | 3,750 | - | - | Direct |
| May 18, 2026 | MGNX MACROGENICS INC | Exercise | 3,750 | - | $0 | Direct |
| Apr 1, 2026 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 686 | - | - | Direct |
| Jan 1, 2026 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 643 | - | - | Direct |
| Oct 1, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 1,642 | - | - | Direct |
| Jul 1, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 3,314 | - | - | Direct |
1-10 of 17 transactions